Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2007 1
2008 1
2010 1
2011 1
2013 1
2014 3
2015 1
2016 5
2017 3
2018 4
2019 4
2020 3
2021 6
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Llibre JM, Brites C, Cheng CY, Osiyemi O, Galera C, Hocqueloux L, Maggiolo F, Degen O, Taylor S, Blair E, Man C, Wynne B, Oyee J, Underwood M, Curtis L, Bontempo G, van Wyk J. Llibre JM, et al. Among authors: degen o. Clin Infect Dis. 2023 Feb 18;76(4):720-729. doi: 10.1093/cid/ciac130. Clin Infect Dis. 2023. PMID: 35235656 Free PMC article. Clinical Trial.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: degen o. Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.
Orkin C, Oka S, Philibert P, Brinson C, Bassa A, Gusev D, Degen O, García JG, Morell EB, Tan DHS, D'Amico R, Dorey D, Griffith S, Thiagarajah S, St Clair M, Van Solingen-Ristea R, Crauwels H, Ford SL, Patel P, Chounta V, Vanveggel S, Cutrell A, Van Eygen V, Vandermeulen K, Margolis DA, Smith KY, Spreen WR. Orkin C, et al. Among authors: degen o. Lancet HIV. 2021 Apr;8(4):e185-e196. doi: 10.1016/S2352-3018(20)30340-4. Lancet HIV. 2021. PMID: 33794181 Clinical Trial.
[Cooperation with the university ambulance].
Degen O. Degen O. MMW Fortschr Med. 2023 Jun;165(Suppl 2):18-19. doi: 10.1007/s15006-023-2604-x. MMW Fortschr Med. 2023. PMID: 37249848 Review. German. No abstract available.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-Cohort.
Schleenvoigt BT, Ankert J, Barten-Neiner G, Voit F, Suttorp N, Boesecke C, Hoffmann C, Stolz D, Pletz MW, Rohde G, Witzenrath M, Panning M, Essig A, Rupp J, Degen O, Stephan C; CAPNETZ Study Group. Schleenvoigt BT, et al. Among authors: degen o. Infection. 2024 Feb;52(1):129-137. doi: 10.1007/s15010-023-02070-3. Epub 2023 Jul 9. Infection. 2024. PMID: 37423969 Free PMC article.
Treatment and Concomitant Infections in Refugees From the Ukraine With HIV.
Matthews H, Koval A, Völker K, Hertling S, Hoffmann C, Schäfer G, Unger S, Schulze Zur Wiesch J, Hüfner AD, Jordan S, Degen O, Schmiedel S. Matthews H, et al. Among authors: degen o. Dtsch Arztebl Int. 2023 Aug 7;120(31-32):540-541. doi: 10.3238/arztebl.m2023.0110. Dtsch Arztebl Int. 2023. PMID: 37721143 Free PMC article. No abstract available.
[HIV First Diagnoses in Germany in 2014 - A Regional Analysis].
Thomas Schleenvoigt B, Ankert J, Stocker H, Stoehr A, Lehmann C, Schulz C, Wesselmann H, Bickel M, Haberl A, Degen O, Pletz MW, Seybold U, Stephan C; für die HIV-Regional Studiengruppe; HIV-regional Studiengruppe Axel Baumgarten, Christoph Boesecke, Carlos Fritzsche, Thomas Heuchel, Stefanie Holm, Andreas Jenke, Heribert Knechten, Christoph Lübbert, Rainer Lundershausen, Anja Meurer, Ramona Pauli, Nils Postel, Katja Römer, Steve Rößler, Ines Ruck, Thomas Seidel, Markus Sellmann, Matthias Stoll, Christoph Spinner, Petra Spornraft-Ragaller, Michael Waizmann, Eva Wolf, Christoph Wyen. Thomas Schleenvoigt B, et al. Among authors: degen o. Gesundheitswesen. 2022 Nov;84(11):e45-e52. doi: 10.1055/a-1665-6762. Epub 2022 Feb 17. Gesundheitswesen. 2022. PMID: 35176792 German.
50 results